Adolore BioTherapeutics, Inc., (”Adolore” or the “Company”), a biotechnology company developing transformational opioid-free intracellularly-delivered treatments for chronic pain, today announced that ...
DELRAY BEACH, FL / ACCESSWIRE / September 24, 2024 / Adolore BioTherapeutics, Inc., ("Adolore" or the "Company"), a biotechnology company developing transformational opioid-free intracellularly-delive ...
Tom Hutch. He is the medical director of the opioid treatment program at We Care Daily Clinics in Auburn, Wash. "Ketamine, at an imperceptibly low dose, helps bridge that gap." Over 14 months ...